Back

Summary and close.

1 May 2017 (13:40 - 13:45)
Organised by:
Congress Presentation Part of: Heart failure: what is the potential of SGLT2 inhibition? Chronic heart failure Open Access Heart Failure 2017 - 4th World Congress on Acute Heart Failure

About the speaker

Photo
Doctor Simon Williams

Manchester (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction.
Doctor S. Williams (Manchester, GB) Doctor J. Day (Luton, GB)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure.
Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
The ongoing problem of heart failure - Q&A.
Doctor S. Williams (Manchester, GB) Professor J. McMurray (Glasgow, GB)
Slides Video
Presentation thumbnail
SGLT2 inhibition: the potential to change the heart failure landscape?
Doctor M. Kosiborod (Kansas City, US)
Slides Video
Presentation thumbnail
SGLT2 inhibition: the potential to change the heart failure landscape? Q&A.
Slides Video

Access the full session

Session thumbnail
Heart failure: what is the potential of SGLT2 inhibition?

The Event

Event poster

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

1 May 2017 13:40 CET
You may be interested in
thumbnail
Congress Presentation
Panel discussion - AXIOMATIC-SSP.
28 August 2022
thumbnail
Congress Presentation
Breaking through: CETP inhibitors and the future of lipid therapy
29 August 2025
thumbnail
Congress Presentation
Program summary and concluding remarks
20 May 2023
thumbnail
Congress Presentation
Design and baseline data of AZURE-LDL, a phase 3 study assessing the effect of the oral PCSK9 inhibitor laroprovstat on LDL cholesterol in patients with, or at risk for, ASCVD
28 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources